Azithromycin: 3-day versus 5-day course in the treatment of respiratory tract infections in children

Journal of Chemotherapy

Volumn 9, Issue 1, 1997, Pages 38-43

  Ficnar, B ^a   Huzjak, N ^a   Oreskovic, K ^b   Matrapazovski, M ^b   Klinar, I ^b  

^a KBC Zagreb   (Croatia)

^b PLIVA CROATIA LTD   (Croatia)

Author keywords

azithromycin; otitis media; pharyngitis; pneumonia; sinusitis; tonsillitis

Indexed keywords

AZITHROMYCIN;

ARTICLE; BLOOD TOXICITY; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; OTITIS MEDIA; PHARYNGITIS; PNEUMONIA; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT INFECTION; SINUSITIS; TONSILLITIS;

EID: 0030887718     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.1997.9.1.38     Document Type: Article

References (13)

1. Mandell GL, Bennet JE, Dolin R, eds. Principles and Practice of Infectious Diseases. New York: Churchill Livingstone, 1995.
2. Peters DH, Heather AF, McTavish D. Azithromycin. A review of its antimicrobial activity, pharmacokinetic properties and clinical efficacy. Drugs 1992; 44: 750-99.
3. Hoepelman IM, Schneider MME. Azithromycin: the first of the tissue-selective azalides. Int J Antimicrob Agents 1995; 5: 145-67.
4. Foulds G, Johnson RB. Selection of dose regimens of azithromycin. J Antimicrob Chemother 1993; 31 (suppl E): 39-50.
5. Daniel RR. Comparison of azithromycin and co-amoxiclav in the treatment of otitis media in children. J Antimicrob Chemother 1993; 31 (suppl E): 65-71.
6. Schaad UB. Multicentre evaluation of azithromycin in comparison with co-amoxiclav for the treatment of acute otitis media in children. J Antimicrob Chemother 1993; 31 (suppl E): 81-8.
7. Principi N, Ambrosioni G, Caramia G, et al. Azithromycin versus amoxicillin/clavulanate in pediatric acute otitis media: comparative, randomized, open study. In: Neu HC, Young LS, Zinner SH, Acar JF, eds. New Macrolides, Azalides, and Streptogramins in Clinical Practice. New York: Marcel Dekker, Inc, 1995: 422-7.
8. Hamill J. Multicentre evaluation of azithromycin and penicillin V in the treatment of acute streptococcal pharyngitis and tonsillitis in children. J Antimicrob Chemother 1993; 31 (suppl E): 89-94.
9. Weippl G. Multicentre comparison of azithromycin versus erythromycin in the treatment of paediatric pharyngitis or tonsillitis caused by group A streptococci. J Antimicrob Chemother 1993; 31 (suppl E): 95-101.
10. Principi N, Marchisio P, Biasini G, et al. Azithromycin versus erythromycin in the treatment of paediatric community-acquired pneumonia. Eur J Clin Res 1993; 4: 127-33.
11. Ronnchetti R, Blasi F, Grossi E, Pecori A and The Azithromycin Pediatric Research Group. The role of azithromycin in treating children with community-acquired pneumonia. Curr Ther Res 1994; 55: 965-70.
12. Hopkins S. Clinical safety and tolerance of azithromycin in children. J Antimicrob Chemother 1993; 31 (Suppl. E): 111-117.
13. Schönwald S, Skerk V, Petricevic I, Car V, Majerus-Misic Lj, Gunjaca M. Comparison of three-day and five-day courses of azithromycin in the treatment of atypical pneumonia. Eur J Clin Microbiol Infect Dis 1991; 10: 877-880.